TrianecT receives €250,000 NWO Take-off 2 for groundbreaking stroke triage device
January 10, 2024
TrianecT is a company developing a breakthrough stroke triage device for patients with acute stroke to be used directly in the ambulance. The funding allows TrianecT to accelerate its mission to bring every stroke patient as quickly as possible to the right hospital for treatment. With a speedy diagnosis in place, patient outcome will be improving drastically.
“In the NWO take-off project, TrianecT will continue expanding our team to further develop the components of our breakthrough medical device as well as our quality management system for regulatory compliance.” Wouter Potters, CEO of TrianecT
Improving treatment through early triage
Each year, 10 million severe stroke patients are picked up by ambulances around the world. Half of these stroke patients can be treated with endovascularly, but this needs to be done as quickly as possible at the right type of hospital. At the moment, a big group of patients are brought to hospitals that do not have endovascular treatment. This results in an average delay of endovascular treatment of 90 minutes, which leads to seriously worsened disease outcomes and a larger burden on society.
TrianecT’s diagnostic triage cap
TrianecT is developing a special cap that combines brain activity measurement (EEG or brain film) and artificial intelligence to detect these treatable stroke patients in the ambulance and bring them directly to the best place for treatment.
Neurologist Jonathan Coutinho, clinical technologist Wouter Potters and professor of radiology Henk Marquering from Amsterdam UMC are the inventors of the smart cap. In 2018, Wouter Potters and Jonathan Coutinho received, among other honours, the Amsterdam Science and Innovation Award and funding from the Heart Foundation to develop their innovative idea into a prototype. The stroke triage cap was tested in practice between 2018 and 2022: twelve ambulances used the medical aid and collected data from approximately 400 patients.
About NWO Take-off
Take-off, the funding instrument available to all scientific fields, encourages activity and entrepreneurship within the Dutch knowledge institutions. With this instrument, academic entrepreneurs can bring their innovative research results to the market. Take-off is one of the instruments for knowledge utilisation which NWO implements together with ZonMw (The Netherlands Organisation for Health Research and Development). Visit NWO website
More news
VU researchers develop research equipment to identify contaminants in water
Water, comprising over 70% of our planet, is the source of all life. The presence of emerging contaminants in our water, including pharmaceuticals, pose serious health and environmental risks, such as DNA damage, reproductive issues, and cancer. New equipment to detect these contaminants developed by VU researchers has been sold to other research groups all over the world. Now the researchers are taking the next step, together with IXA, to expand sales to water companies worldwide as well as other applications such as food and drug discovery research.
News
Tackling learning difficulties in Academic Workplace
The Academic Workplace Rudolf Berlin Center (AW RBC) aims to make a meaningful contribution by supporting young people with learning disabilities through enhanced education and care.
News
Contribute to Amsterdam’s Future: test your innovation at SAIL and the Amsterdam Marathon
Are you looking for a testing ground for your innovation? SAIL and the Amsterdam Marathon present an excellent opportunity to test your ideas. These major events attract millions of visitors and come with sustainability, accessibility, and logistical challenges that need fresh solutions. The In Residence Events program allows you to test your innovation during these […]
News